Health Outcomes Solutions (United States)

An AI-Based Whole-Person Care Summarization Tool for Care Management Providers

To provide effective care and support to patients with complex medical and social needs, providers must have synthesized whole-person insights on their health-related social needs (HRSN). Often, the only sources of these insights are large numbers of unstructured data coming from...

Building recovery capital through an integrated educational and fitness substance use programme: a patient and public involvement (PPI) approach

Purpose The purpose of this study is to examine how an integrated substance use educational and fitness programme, Boxing Clever, can help to cultivate recovery capital (RC) for individuals currently or historically engaged in problematic substance use. Design/methodology/approac...

Loneliness, not isolation, is the missing link between social connectedness and mental health among midlife to older U.S. adults

Objectives To investigate whether loneliness or social isolation serves as the main pathway connecting social connectedness dimensions to mental health outcomes among midlife to older adults.Methods We examined longitudinal data from 4,963 adults aged 40–65 at baseline in the U.S...

Erythropoietic protoporphyria life impact and genetic health trajectory (LIGHT) study in Europe: a cross-sectional online questionnaire

Abstract Background Erythropoietic protoporphyria and X-linked protoporphyria (collectively, EPP) are rare inherited metabolic disorders of the heme biosynthetic pathway characterized by severe photosensitivity and painful phototoxic reactions upon sunlight exposure. This study s...

Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review

The introduction of precision therapy in severe asthma is shifting treatment goals from asthma control towards the more ambitious target of clinical remission. This study evaluated clinical remission in patients with severe asthma receiving mepolizumab in Europe. A retrospective,...